3.87

6.07% -0.25

Treace Medical Concepts Inc (TMCI)

Overview News Price History Option Chain Financials Discussions Forecast

Treace Medical Concepts Inc stock is traded at $3.87, with a volume of 131.57K. It is down -6.07% in the last 24 hours and down -15.13% over the past month. Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The company operates and manages its business as a single segment: designing, manufacturing, and marketing medical devices for surgeons, ambulatory surgery centers, and hospitals related to the surgical management of bunion and related midfoot deformities.

Previous Close:

$4.12

Open:

$4.1

24h Volume:

131.57K

Relative Volume:

0.56

Market Cap:

$251.68M

Revenue:

$207.32M

Net Income/Loss:

$-61.04M

P/E Ratio:

-4.0409

EPS:

-0.9577

Net Cash Flow:

$-25.97M

1W Performance:

-2.03%

1M Performance:

-15.13%

6M Performance:

+106.95%

1Y Performance:

-39.34%

1-Day Range:

$3.87

$4.115

1-Week Range:

$3.87

$4.21

52-Week Range:

$1.17

$7.08

Treace Medical Concepts Inc Stock (TMCI) Company Profile

Name

Treace Medical Concepts Inc

Sector

Healthcare (1052)

Industry

Medical Devices (143)

Phone

(904) 373-5940

Address

100 PALMETTO PARK PLACE, PONTE VEDRA

Employee

450

Twitter

Next Earnings Date

2026-11-05

Latest SEC Filings

TMCI's Discussions on Twitter

Compare TMCI vs ABT, MDT, SYK, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TMCI Treace Medical Concepts Inc	3.87	251.68M	207.32M	-61.04M	-25.97M	-0.9577
ABT Abbott Laboratories	104.89	181.50B	46.59B	5.41B	7.38B	3.0938
MDT Medtronic Plc	94.75	121.20B	36.36B	4.84B	5.43B	3.7261
SYK Stryker Corp	294.66	113.02B	25.27B	3.34B	4.57B	8.6334
BSX Boston Scientific Corp	44.39	64.33B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	86.60	49.92B	6.30B	1.07B	1.09B	1.8406

Treace Medical Concepts Inc Stock (TMCI) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-07-25	Downgrade	BTIG Research	Buy → Neutral
Nov-07-25	Downgrade	JP Morgan	Neutral → Underweight
Feb-04-25	Upgrade	BTIG Research	Neutral → Buy
Dec-31-24	Initiated	Lake Street	Buy
Dec-17-24	Resumed	JP Morgan	Neutral
May-16-24	Downgrade	UBS	Buy → Neutral
May-08-24	Downgrade	BTIG Research	Buy → Neutral
May-08-24	Downgrade	JP Morgan	Overweight → Neutral
May-08-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight
May-08-24	Downgrade	Stifel	Buy → Hold
May-08-24	Downgrade	Truist	Buy → Hold
Sep-29-23	Initiated	UBS	Buy
May-01-23	Initiated	Truist	Buy
Apr-11-23	Initiated	Stephens	Equal-Weight
May-12-22	Initiated	BTIG Research	Buy
Jan-07-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight
May-18-21	Initiated	JP Morgan	Overweight
May-18-21	Initiated	Morgan Stanley	Equal-Weight
May-18-21	Initiated	SVB Leerink	Outperform
May-18-21	Initiated	Stifel	Buy

View All

Treace Medical Concepts Inc Stock (TMCI) Latest News

Oct 09, 2026

Treace Medical Concepts (TMCI) Eases to $3.84 as Shares Hug the Lower Half of a Defined RangeKey Reversal Day - https://www.dars.gov.et/

Oct 09, 2026

Oct 02, 2026

Form 4 Treace Medical Concepts Inc For: 2 October By Investing.com - Investing.com Nigeria

Oct 02, 2026

Form 4 Treace Medical Concepts Inc For: 2 October By Investing.com - Investing.com Australia

Oct 02, 2026

25,457 shares were delivered or withheld at Treace Medical (TMCI), leaving 753,226 directly held. - Stock Titan

Oct 02, 2026

Sep 30, 2026

Treace Medical Concepts, Inc. (NASDAQ:TMCI) Stock Has Consensus Target Price of $5.17 According to Brokerages - MarketBeat

Sep 30, 2026

Sep 26, 2026

Bank of America Corp DE Acquires 3,305,100 Shares of Treace Medical Concepts, Inc. $TMCI - MarketBeat

Sep 26, 2026

Sep 24, 2026